Scoring model with serum albumin and CA19-9 for metastatic pancreatic cancer in second-line treatment: results from the NAPOLEON study

ConclusionThe survival advantage of second-line CTx, was observed in patients with scores of 0 and 1 but not in those with score 2.
Source: International Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research